go back

BCR-ABL1 Major Breakpoint Measurement

Vermont rates for HCPCS 0040U

Used in chronic myeloid leukemia to measure how much of the abnormal BCR-ABL1 gene fusion is present, which shows how the disease is responding. It reports a quantity for the major breakpoint form of the fusion only; a companion test covers both breakpoint forms.

Rates data updated July 2026.

Facilitymedian $407 · 10th–90th $407$6920%20%40%90th$407Professionalmedian $562 · 10th–90th $316$5620%50%10th$562$200.0$500.0$1.0K$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$316.23
Median
$562.34
Typical High
$562.34
Cigna
Setting
Facility
Modifier
Global
Typical Low
$691.83
Median
$691.83
Typical High
$691.83
MVP Health Care
Setting
Facility
Modifier
Global
Typical Low
$407.38
Median
$407.38
Typical High
$407.38
MVP Health Care
Setting
Professional
Modifier
Global
Typical Low
$407.38
Median
$407.38
Typical High
$457.09
United
Setting
Professional
Modifier
Global
Typical Low
$186.21
Median
$457.09
Typical High
$1,862.09